Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified Health Condition 2: N926- Irregular menstruation, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.ASA grade 1 and 2 patients
Exclusion criteria
Exclusion criteria: 1.Emergency surgeries 2.BMI > 40kg/m2 3.Patients with known allergy to the drugs used in study 4.Patients with renal insufficiency 5.Neuromuscular diseases 6.Hepatic dysfunction 7.Cardiac disease 8.Previous oncological surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score in both the groupTimepoint: 0hr, 4hr, 8 hr, 12hr , 16hr, 20 hr , 24hr | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢Total analgesic requirement in the two groups in first 24 hours â?¢Time (in minutes) to request first analgesic in both groups â?¢Frequency of occurrence of side-effects of magnesium sulphateTimepoint: 0 hour, 4 hours, 8 hours , 12 hours , 16 hours, 20 hours, 24 hours | — |
Countries
India
Contacts
pushpagiri medical college and research centre thiruvalla